Section Arrow
AORT.NYSE
- Artivion
Quotes are at least 15-min delayed:2026/11/20 17:26 EST
After Hours
Last
 18.16
0 (0.00%)
Bid
16.1
Ask
18.22
High 18.16 
Low 18.16 
Volume 8.31K 
Regular Hours (Closed)
Last
 18.16
-0.37 (-2.00%)
Day High 
18.93 
Prev. Close
18.53 
1-M High
27 
Volume 
642.10K 
Bid
16.1
Ask
18.22
Day Low
18.13 
Open
18.52 
1-M Low
18.115 
Market Cap 
904.07M 
Currency 美元 
P/E 105.24 
%Yield 0.17 
10-SMA 19.37 
20-SMA 21.55 
50-SMA 22.35 
52-W High 48.25 
52-W Low 18.115 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-0.36/0.42
Enterprise Value
1.16B
Balance Sheet
Book Value Per Share
9.15
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
388.54M
Operating Revenue Per Share
9.05
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 41.9407 -0.0393 -0.09%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.61 -0.02 -1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.89 -0.05 -0.05%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.9699 +0.0609 +6.70%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103 0 0.00%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.